Back

Tempus AI falls 2.18% despite Cantor Fitzgerald’s $80 price target

Verifying
  • Cantor Fitzgerald initiated Tempus AI coverage with an Overweight rating and $80 price target.
  • Tempus AI shares fell 2.18% to $60.91 Wednesday, Benzinga Pro data showed.
  • Tempus serves 19 of the 20 largest pharmaceutical companies and more than 250 biotechs.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.